CRSP - CRISPR Therapeutics Operatsion marja

CRISPR Therapeutics AG (CRSP) kompaniyasining rasmiy ramzlari

CRISPR Therapeutics AG (CRSP) narxlar urushlaridan qochgan holda genom tahrirlash nishasini egallab turibdi. Operatsion marja grafigi ushbu barqarorlikni vizuallashtiradi, bunda -2058.60 belgisi asosiy ko'rsatkich vazifasini o'taydi. Kompaniyaga tegishli kapital yuqori xarajatli terapiya va litsenziyalarga asoslangan. Muvaffaqiyatlar zamonaviy ilmiy institut muhitida noyob patologiyalarni yengishga intilayotgan innovatsion biologlarning dadil gipotezalari hisobiga ta'minlanmoqda.

CRSP - CRISPR Therapeutics Inc Operatsion marja 04.07.2022 - 20.11.2026 oraligʻida

CRSP (CRISPR Therapeutics AG): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:CRSP, CRISPR
CRISPR tayyor mahsulotlari

Operatsion marja soliqlar va foiz majburiyatlarini hisobga olguncha, tushumlar tuzilmasi ichida asosiy operatsiyalardan olingan foyda ulushini ifodalash orqali xarajatlarni boshqarish samaradorligini baholaydi. Gen tahrirlash sohasining kashshofi bo'lgan CRISPR Therapeutics AG (CRSP) uchun ushbu ko'rsatkich operatsion marja xronologiyasida aniq ko'rsatilganidek, ilmiy obro'ning tijoriy barqarorlikka aylanishini aks ettiradi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion foyda normasi WGS|RARE - Operatsion rentabellik|Beam Tx (BEAM) - Sotuvning operatsion marjasi|SRPT (Sarepta Therapeutics Inc) - Sotuvning operatsion marjasi|TWST: Operatsion foyda koeffitsiyenti|TXG (10xgenomics.com) - Operatsion marja|NTLA (Intellia Therapeutics, Inc.) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Stoke Corp (STOK)|Operatsion faoliyat rentabelligi BioLife|Operatsion marja WVE (Wave Life Sciences Ltd)|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik